EU regulators reverse course, approve Alzheimer’s drug Leqembi
HQ Team November 19, 2024: The European Medicines Agency (EMA) granted conditional approval for lecanemab, for the treatment of early Alzheimer’s disease in.
Health
Uncategorized
Drugs
Health
Pharma
EMA starts review of medicines to treat hair loss, prostate enlargement
The European Medicines Agency is reviewing two medicines meant to treat hair loss and prostate enlargement following concerns regarding suicidal ideation and behaviours.
Drugs
Health
Pharma
Novo’s Wegovy gets EMA nod to treat heart failure in obese people
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.
Drugs
Health
Pharma
Wegovy gets EU regulator backing on lowering heart risks in obese people
The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.
Drugs
Health
Pharma
Bayer acquires marketing rights for heart drug in Europe for $310 million
HQ Team March 4, 2024: Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a.
Drugs
Health
Pharma
Pfizer says RSV vaccine can ensure protection into second season
HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.
Drugs
Health
Pharma
BioMarin’s achondroplasia drug gets nod for children of all ages
HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.
Drugs
Health
Pharma
EMA cautions against topiramate medicine use during pregnancy
HQ Team September 2, 2023: A panel of the European Union’s health regulator, the European Medicines Agency, has warned against the use of.